BWLFG - POTASSIUM CHLORIDE INJ., USP
- MSDS: BWLFG
- Manufacturer: ABBOTT LABORATORIES DIAGNOSTICS DIV
- Product Name: POTASSIUM CHLORIDE INJ., USP
- National Stock Number: 6505-01-080-1987
Product Identification
Product ID:POTASSIUM CHLORIDE INJ., USP
MSDS Date:06/20/1991
FSC:6505
NIIN:01-080-1987
MSDS Number: BWLFG
Responsible Party
ABBOTT PARK, IL 60064-9078
US
Emergency Phone: 708-937-7970/800-323-9100
Info Phone: 708-937-6100
Cage: 0ALT7
Contractor
Telephone: 800-255-5162/847-937-7970
Cage: 0BJ95
Ingredients
POTASSIUM CHLORIDE
CAS: 7447-40-7
RTECS: TS8050000
AQUEOUS SOLUTION
Fraction By Weight: 100%
Hazards
LD50 LC50 Mixture:LD50(RAT,ORAL)=2500-3314MG/KG.
Routes of Entry: Inhalation:NO Skin:YES Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:EYE IRRITANT. OVERDOSAGE CAN LEAD TO
HYPERKALEMIA(TOO MUCH POTASSIUM),WEAKNESS,CARDIAC ARREST,
CARDIOVASCULAR COLLAPSE.MORE COMMON ADVERSE REACTIONS ARE
VOMIT,NAU,ABDOMINAL DISCOMFORT,DIARR DUE TO GI TRACT IRRIT.USE OF
POTASSIUM CHLORIDE HAS LEAD TO BLEEDING & GASTRIC ULCERATION IN
SOME PATIENTS.
Explanation of Carcinogenicity:PER MSDS:CARCINOGEN:NOT LISTED.
Effects of Overexposure:EYE IRRITANT. HYPERKALEMIA, WEAKNESS, CARDIAC
ARREST, CARDIOVASCULAR COLLAPSE, VOMITING, NAUSEA, ABDOMINAL
DISCOMFORT, DIARRHEA, BLEEDING & GASTRIC ULCERATION.
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MFG. TARGET
ORGANS:EYE, HEART, GI TRACT.
First Aid
First Aid:SCRUB & WASH EXPPOSED PARTS WELL W/SOAP & WATER. INGEST:CALL
PHYSICIAN. EYE:WASH WITH WATER FOR @LEAST 15MINS. CALL PHYSICIAN.
Fire Fighting
Flash Point:NON-FLAMMABLE
Extinguishing Media:PER MSDS N/A. HOWEVER USE APPROPRIATE EXTINGUISHING
MEDIA FOR SURROUNDING FIRES.
Fire Fighting Procedures:NONE.
Unusual Fire/Explosion Hazard:NONE.
Accidental Release
Spill Release Procedures:ABSORB WITH SUITABLE MATERIAL, FLUSH WITH
WATER.
Handling
Handling and Storage Precautions:NONE.
Other Precautions:POTASSIUM IS AN ESSENTIAL MINERAL. POTASSIUM CHLORIDE
IS ADMINISTERED ORALLY WHEN POTASSIUM IN BODY HAS BEEN DEPLETED.
USUAL CLINICAL DOSE RANGES BETWEEN 750-6000MG/DAY IN FORM OF
TABLETS OR POWDER FO R ORAL SOLUTION.
Exposure Controls
Respiratory Protection:NONE REQUIRED.
Ventilation:NO SPECIAL PROVISIONS REQUIRED.
Protective Gloves:RUBBER GLOVES.
Eye Protection:SAFETY GLASSE, GOGGLES.
Work Hygienic Practices:WASH HANDS AFTER HANDLING.
Supplemental Safety and Health
Chemical Properties
HCC:N1
Spec Gravity:WATER(APPROX)
pH:3.5-8
Viscosity:WATER(APPROX)
Solubility in Water:AQUEOUS SOLUTION
Appearance and Odor:CLEAR LIQUID.
Percent Volatiles by Volume:NEGLIG
Stability
Stability Indicator/Materials to Avoid:YES
VIOLENT REACTION WITH BRF3 (H2SO4 AND KMNO4).
Stability Condition to Avoid:NONE.
Hazardous Decomposition Products:WHEN HEATED TO DECOMPOSITION, IT EMITS
TOXIC FUMES OF CL.
Disposal
Waste Disposal Methods:DISPOSE OF SOLUTION IN SEWER. BURY IN LANDFILL.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.